Navigation Links
Doctors should stop prescribing antibiotics for the common cold, review advises

Antibiotics should not be prescribed to patients with the common cold because there is scant evidence they stop other infections, and the benefits do not outweigh the risks, according to a new systematic review of current evidence.

"Antibiotics appear to have no benefit in the treatment of acute upper respiratory tract infections," conclude Dr. Bruce Arroll and Dr. Timothy Kenealy of the University of Auckland, New Zealand. "The implications for practice are that prescription of antibiotics should not be given in the first instance as they will not improve the symptoms and adult patients will get adverse effects."

In addition to the side effects, mainly diarrhea, "overuse can increase levels of antibiotic resistance in the community," the review advises.

Colds are caused by viruses and not bacteria, upon which antibiotics act, yet, says Arroll, "There is evidence of high usage of antibiotics for the common cold in spite of doubts about the efficacy of such therapy." The review appears in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic. Arroll reviewed 12 trials that included more than 1,900 patients with symptoms lasting for seven days or less or with colds that included runny noses with colored discharge for 10 days or less. The patients had been given either antibiotics or placebo. "People receiving antibiotics did no better in terms of lack of cure or persistence of symptoms than those on placebo," Arroll says.

The goal of the study, according to the authors, was to determine if antibiotics reduce general cold symptoms such as sneezing, inflammation of the nose and throat; if antibiotics have any effect on pus-like nasal discharge; and if antibiotics have significant side eff ects in people with colds.

Although there may be some benefit of using antibiotics to treat the runny nose with colored discharge (acute purulent rhinitis), "their routine use is not recommended," the review says.

Colds are the most common reason for new patient visits at general practioners' offices, the review reports, and although the antibiotics do not work for that purpose, it is the second most common reason doctors prescribe them, Arroll writes.

"Physicians prescribe antibiotics in these cases out of habit and/or because they do not agree with the evidence," says Dr. Arroll. "Antibiotics do work for a minority of patients with purulent rhinitis, one out of five, so they may generalize this experience to their wider patient group."

Dr. Norman H. Edelman, chief medical officer for the American Lung Association, says, "There is no simple answer as to why providers do this. Some physicians may want to prevent complications of bacterial infections, which do occur. Some may be yielding to pressure from patients." But he says "this practice is on the decline as the public becomes more sophisticated about health issues."

Dr. Arroll says that patients are not doing themselves any favors looking for a "quick fix" in pressuring their providers to prescribe antibiotics for colds. "Patients will get a quicker fix if they take decongestants such as pseudoephedrine (Sudafed)," he says.


Source:Center for the Advancement of Health

Related biology news :

1. Doctors closer to using gene analysis to help trauma patients
2. New Discovery May Help Doctors Treat Infertility
3. Tsunami-damaged coral reefs should be left to recover naturally, say scientists
4. Newest HIV drugs should be used with FUZEON(R)
5. Discovery of an American salamander where it shouldnt be: Korea
6. Scientists discover stem cell origin of neck and shoulders
7. WCS says avian flu prevention should focus on farms, markets
8. Brains response to visual stimuli helps us to focus on what we should see, rather than all there is to see
9. Tsunami + 1 year: Reviving exhausted fisheries should trump replacing boats, gear, experts say
10. Minimal genome should be twice the size, study shows
11. How the US drug safety system should be changed
Post Your Comments:

(Date:11/12/2015)... , Nov. 11, 2015   Growing need ... analytical tools has been paving the way for ... determination of discrete analytes in clinical, agricultural, environmental, ... being predominantly used in medical applications, however, their ... sectors due to continuous emphasis on improving product ...
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
(Date:11/4/2015)... 4, 2015 --> ... published by Transparency Market Research "Home Security Solutions Market - ... 2015 - 2022", the global home security solutions market is expected ... 2022. The market is estimated to expand at a ... to 2022. Rising security needs among customers at homes, ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... IN (PRWEB) , ... November 24, 2015 , ... The ... newest Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent ... the last few years. Many AMA members have embraced this type of racing and ...
Breaking Biology Technology: